Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation
Sulabha Ranganathan(Incyte (United States)), Kenneth D. Tew(Medical University of South Carolina), Eileen S. Walsh(Janssen (Switzerland)), Paul J. Ciaccio(Fox Chase Cancer Center)
Cited by 68
Related Papers
A T-cell–redirecting bispecific G-protein–coupled receptor class 5 member D x CD3 antibody to treat multiple myeloma
|Blood|2020|167
Kinesin Spindle Protein (KSP) Inhibitors. 9. Discovery of (2<i>S</i>)-4-(2,5-Difluorophenyl)-<i>N</i>-[(3<i>R</i>,4<i>S</i>)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-<i>N</i>-methyl-2-phenyl-2,5-dihydro-1<i>H</i>-pyrrole-1-carboxamide (MK-0731) for the Treatment of Taxane-Refractory Cancer
|Journal of Medicinal Chemistry|2008|157
Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP
|Bioorganic & Medicinal Chemistry Letters|2005|137
PABA/NO as an Anticancer Lead: Analogue Synthesis, Structure Revision, Solution Chemistry, Reactivity toward Glutathione, and in Vitro Activity
|Journal of Medicinal Chemistry|2006|92
3-Aminopyrrolidinone Farnesyltransferase Inhibitors: Design of Macrocyclic Compounds with Improved Pharmacokinetics and Excellent Cell Potency
|Journal of Medicinal Chemistry|2002|86